Hereditary Transthyretin-mediated Amyloidosis Now new on the German Pharmaceutical Market: EU-Approval of Tegsedi (Inotersen)

[Anonymous]

VISCERAL MEDICINE, 2018; 34 (4): 321

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索